SC-69000

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSC-69000
Drug Alias NameSC-69000
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-V/beta-3 antagonists
TargetsIntegrin alpha-V/beta-3
Therapy Area/IndicationsAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesG. D. Searle & Co
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesG. D. Searle & Co
Active IndicationsN/A
Inactive IndicationsAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A